MCS
“Unlocking Regeneration, Redefining Health”
MSCs are the most widely used and promising cell therapy product in our pipeline. With unique immunomodulatory, anti-inflammatory, and tissue repair capabilities, they hold transformative potential not only for metabolic, autoimmune, degenerative, aging-related diseases, but also for broader health and wellness applications.
Product Overview
Our MSC platform employs advanced culture systems tailored to specific therapeutic needs. MSCs restore immune balance, promote tissue regeneration and modulate inflammatory responses. The primary mechanisms of MSCs include directed differentiation into functional cell types, homing to sites of injury or disease, and secretion of bioactive molecules to support immune regulation and tissue repair. In addition, by leveraging our gene editing platform, we engineer MSCs with enhanced functionality and therapeutic efficacy, further expanding their potential in complex diseases and regenerative medicine.
Advantages
Directed Differentiation: MSCs can differentiate into multiple functional cell types, enabling tissue regeneration across different body systems.
Homing Ability: MSCs actively migrate to sites of injury or disease, where they exert therapeutic effects directly at the affected area.
Paracrine Secretion: By releasing cytokines, growth factors, exosomes, and other bioactive molecules, MSCs regulate immune responses, reduce inflammation, and enhance tissue repair.
Enhanced Performance: Leveraging our gene editing platform, MSCs are engineered with improved therapeutic efficacy and broader clinical potential.
Clinical Applications
Degenerative Diseases: Osteoarthritis, neurodegenerative disorders (e.g., Alzheimer’s. Parkinson’s), and tissue repair for trauma and chronic wounds.
Autoimmune Diseases: Rheumatoid arthritis, SLE, and GVHD.
Metabolic & Endocrine Disorders: Diabetes, PKU, fatty liver disease, and thyroid disorders.
General Health & Wellness: Anti-aging programs, cardiovascular health, reproductive function, and wellness-oriented applications.
R&D Progress
Applied for invention patents in MSC-based PKU therapies.
Research Focus: degenerative diseases, autoimmune diseases, metabolic regulation (including diabetes), and general health & longevity programs.
Future Outlook: continued expansion of MSC pipelines under the Longevity+ Plan, driving innovation in regenerative medicine and healthy aging.